Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 108

Sort by

Sort Order Select

Journal Articles

ATRA Can Correct Impaired Proplatelet Formation By Regulating HIF-1α/SPHK2/S1P Axis in ITP

Qiusha Huang, FengQi Liu, Qi Chen, Gaochao Zhang, Xueyan Sun, Chen-Cong Wang, Li-Ping Yang, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3940.

https://doi.org/10.1182/blood-2023-184311

Published: 2023

Journal Articles

The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy

Yun He, Haixia Fu, Xiaolu Zhu, Qiusha Huang, Qi Chen, Jin Wu, Yuxiu Chen, Peng Zhao, Kai-Yan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 1213.

https://doi.org/10.1182/blood-2023-185453

Published: 2023

Journal Articles

Prednisone Plus Ivig Compared with Prednisone for Immune Thrombocytopenia during Pregnancy

Yuxiu Chen, Mengyu Xiao, Zhuoyu An, Menglin Li, Qingyuan Qu, Jianying Zhou, Haixia Fu, Kai-Yan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 803.

https://doi.org/10.1182/blood-2023-186151

Published: 2023

Journal Articles

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Blood (2023) 142 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2023-184415

Published: 2023

Journal Articles

Donor Macrophage Pyroptosis Contributed to the Development of aGVHD

Xueyan Sun, Qingyuan Qu, Yuxiu Chen, Menglin Li, Fengqi Liu, Qi Chen, Haixia Fu, Xiaohui Zhang, Xiangyu Zhao

Blood (2023) 142 (Supplement 1): 2194.

https://doi.org/10.1182/blood-2023-186441

Published: 2023

Journal Articles

The Combination of Iguratimod and Danazol Versus Danazol As a Treatment of Corticosteroid-Resistant/Relapse Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-Label Trial

Xiaolu Zhu, Hui Liu, Zhao Wang, Zhongxing Jiang, Liangming Ma, Min Wang, Jiamin Zhang, Zhuoyu An, Yejun Wu, Yun He, Haixia Fu, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiao Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2589.

https://doi.org/10.1182/blood-2023-184342

Published: 2023

Journal Articles

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Zhuo-Yu An, Yun He, Xiao-lu Zhu, Qiu-Sha Huang, Jin Wu, Haixia Fu, Yuan-Yuan Zhang, Ying-jun Chang, Xiangyu Zhao, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2582.

https://doi.org/10.1182/blood-2023-188139

Published: 2023

Journal Articles

Evaluation of ISTH Severe Bleeding Criteria and Development of a Mortality Prognosis Model for Hospitalized Immune Thrombocytopenia Patients: A Multicenter, Retrospective and Prospective Cohort Study

Zhuo-Yu An, Haixia Fu, Yun He, Xiaolu Zhu, Jin Wu, Qiu-Sha Huang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2580.

https://doi.org/10.1182/blood-2023-187920

Published: 2023

Journal Articles

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

Song Wang, Yan Zhu, Xiaolu Zhu, Haixia Fu, Yun He, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Chenhua Yan, Yuhong Chen, Xiangyu Zhao, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2154.

https://doi.org/10.1182/blood-2023-184380

Published: 2023

Journal Articles

A Prognostic Score Model for Relapsed/Refractory Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Yue Jin, Haixia Fu, Yuhong Chen, Yuanyuan Zhang, Jing-Zhi Wang, Xiao-Dong Mo, Huan Chen, Yao Chen, Yu Wang, Ying-Jun Chang, Lanping Xu, Kai-yan Liu, Xiao-Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 4237.

https://doi.org/10.1182/blood-2023-184701

Published: 2023

Journal Articles

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Blood (2023) 142 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2023-189104

Published: 2023

Journal Articles

Iguratimod Regulates CD4+ T-Cell Homeostasis and Function By Restoring PINK1/Parkin-Mediated Mitophagy in Immune Thrombocytopenia

Yuxiu Chen, Kai-Yan Liu, Haixia Fu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 279.

https://doi.org/10.1182/blood-2023-185876

Published: 2023

Journal Articles

Mega-Dose Decitabine Intensified Regimen Is More Effective at Eliminating Pre-HSCT Measurable Residual Disease Compared to the Bu/Cy Regimen: A Multicenter Prospective Phase II Study

Hao Zheng, Meng Lv, Chenhua Yan, Jing Liu, Yuanyuan Zhang, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiao-Jun Huang

Blood (2023) 142 (Supplement 1): 471.

https://doi.org/10.1182/blood-2023-188932

Published: 2023

Journal Articles

High Rates of Remission with the Initial Treatment of Oral Selinexor Plus CHOP for Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes Analysis of a Multi-Center Phase II Study in China

Kaiyang Ding, Jie Ma, Xiaohui Zhang, Chunling Wang, Huang Hongming, Lixia Sheng, Hailing Liu, Lei Cao, Wei Wu, Jianyong Li, Lei Fan

Blood (2023) 142 (Supplement 1): 1696.

https://doi.org/10.1182/blood-2023-182553

Published: 2023

Journal Articles

Projected Global Trends in Hematological Malignancies: Incidence, Mortality, and Disability-Adjusted Life Years from 2020 to 2030

Zhuo-Yu An, Haixia Fu, Yun He, Xiaolu Zhu, Qiu-Sha Huang, Jin Wu, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3810.

https://doi.org/10.1182/blood-2023-187856

Published: 2023

Journal Articles

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Menglin Li, Haixia Fu, Yi Liu, Hui Liu, Ru Feng, Zhao Wang, Jingwen Wang, Yuxiu Chen, Qingyuan Qu, Mengyu Xiao, Jianying Zhou, Yun He, Xiaolu Zhu, Yuan Kong, Yingjun Chang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3951.

https://doi.org/10.1182/blood-2023-182669

Published: 2023

Journal Articles

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Blood (2023) 142 (Supplement 1): 4951.

https://doi.org/10.1182/blood-2023-184407

Published: 2023

Journal Articles

Only FLT3-ITD Mutation Did Not Have a Deleterious Effect on Acute Myeloid Leukemia Patients with NPM1 Mutation, but Concomitant with DNMT3A Mutation or a＜3log Reduction of MRD2 Predicted Poor Survival

Wenbing Duan, Jinsong Jia, Jing Wang, Xiaohong Liu, Lizhong Gong, WenJing Yu, Xiaolu Zhu, Zhao Ting, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Yu Wang, Hongxia Shi, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jiang

Blood (2023) 142 (Supplement 1): 4309.

https://doi.org/10.1182/blood-2023-184769

Published: 2023

Journal Articles

Iguratimod Could Correct the Defective IL-35-Mediated Megakaryopoiesis in Immune Thrombocytopenia

Xuan Cai, Ruoyun Gui, Jin Wu, Chen-Cong Wang, Xiaolu Zhu, Haixia Fu, Kai-yan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2677.

https://doi.org/10.1182/blood-2023-184543

Published: 2023

Journal Articles

Oligoclonal Bands in CSF May be Associated with Chronic Graft Versus Host Disease after Haploidentical Hematopoietic Stem Cell Transplantation

Chen Zhao, Haixia Fu, Yuhong Chen, Yuanyuan Zhang, Jing-Zhi Wang, Xiao-Dong Mo, Huan Chen, Yu Wang, Ying-Jun Chang, Lanping Xu, Kai-yan Liu, Xiao-Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 7012.

https://doi.org/10.1182/blood-2023-184639

Published: 2023

NARROW

ATRA Can Correct Impaired Proplatelet Formation By Regulating HIF-1α/SPHK2/S1P Axis in ITP

The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy

Prednisone Plus Ivig Compared with Prednisone for Immune Thrombocytopenia during Pregnancy

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Donor Macrophage Pyroptosis Contributed to the Development of aGVHD

The Combination of Iguratimod and Danazol Versus Danazol As a Treatment of Corticosteroid-Resistant/Relapse Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-Label Trial

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Evaluation of ISTH Severe Bleeding Criteria and Development of a Mortality Prognosis Model for Hospitalized Immune Thrombocytopenia Patients: A Multicenter, Retrospective and Prospective Cohort Study

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

A Prognostic Score Model for Relapsed/Refractory Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Iguratimod Regulates CD4+ T-Cell Homeostasis and Function By Restoring PINK1/Parkin-Mediated Mitophagy in Immune Thrombocytopenia

Mega-Dose Decitabine Intensified Regimen Is More Effective at Eliminating Pre-HSCT Measurable Residual Disease Compared to the Bu/Cy Regimen: A Multicenter Prospective Phase II Study

High Rates of Remission with the Initial Treatment of Oral Selinexor Plus CHOP for Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes Analysis of a Multi-Center Phase II Study in China

Projected Global Trends in Hematological Malignancies: Incidence, Mortality, and Disability-Adjusted Life Years from 2020 to 2030

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Only FLT3-ITD Mutation Did Not Have a Deleterious Effect on Acute Myeloid Leukemia Patients with NPM1 Mutation, but Concomitant with DNMT3A Mutation or a＜3log Reduction of MRD2 Predicted Poor Survival

Iguratimod Could Correct the Defective IL-35-Mediated Megakaryopoiesis in Immune Thrombocytopenia

Oligoclonal Bands in CSF May be Associated with Chronic Graft Versus Host Disease after Haploidentical Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only